Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 3, keine Gesamtzahl für „Identified“
Suchtreffer
Begriffe & Kennungen
Dzuveo · 4.8 · Adverse reactions identified either from clinical studies or from post marketing experience with other medicin
Eintrag öffnenEbvallo · 4.8 · Table 2: Adverse reactions identified with Ebvallo System organ class (SOC) Adverse reaction Frequency Infecti
Eintrag öffnenEdurant · 4.8 · There were no new safety concerns identified in the week 240 analysis of the TMC278-C213 Cohort 1 trial in ado
Eintrag öffnenEdurant · 4.8 · There were no new safety concerns identified in the week 240 analysis of the TMC278-C213 Cohort 1 trial in ado
Eintrag öffnenEfavirenz Teva · 4.8 · Information regarding post-marketing surveillance † These adverse reactions were identified through post-marke
Eintrag öffnenEfficib · 4.8 · 8 Table 1: The frequency of adverse reactions identified from placebo-controlled clinical studies of sitaglipt
Eintrag öffnenElonva · 4.8 · *Adverse reactions were identified through post-marketing surveillance.
Eintrag öffnenEmblaveo · 4.8 · The following ADRs have been reported with aztreonam alone and/or identified during Phase 2 and Phase 3 clinic
Eintrag öffnenEmtricitabine/Tenofovir disoproxil Krka · 4.8 · Pre-exposure prophylaxis No new adverse reactions to emtricitabine/tenofovir disoproxil were identified from t
Eintrag öffnenEmtricitabine/Tenofovir disoproxil Mylan · 4.8 · Pre-exposure prophylaxis: No new adverse reactions to emtricitabine/tenofovir disoproxil were identified from
Eintrag öffnenEnzalutamide Viatris · 4.8 · Table 1: Adverse reactions identified in controlled clinical trials and post-marketing
Eintrag öffnenEpclusa · 4.5 · As Epclusa contains sofosbuvir and velpatasvir, any interactions that have been identified with these active s
Eintrag öffnenEpclusa · 4.5 · As Epclusa contains sofosbuvir and velpatasvir, any interactions that have been identified with these active s
Eintrag öffnenEpclusa · 4.8 · Table 5: Adverse drug reactions identified with Epclusa
Eintrag öffnenEpclusa · 4.8 · Table 5: Adverse drug reactions identified with Epclusa
Eintrag öffnenEtcamah · 4.8 · Adverse drug reactions identified for Etcamah in the Etcamah and CDK4/6 inhibitors combination are visual effe
Eintrag öffnenFampyra · 4.8 · Adverse reactions identified are mostly neurological and include seizure, insomnia, anxiety, balance disorder,
Eintrag öffnenForxiga · 4.8 · The following adverse reactions have been identified in the placebo-controlled clinical studies and postmarket
Eintrag öffnenFosavance · 4.8 · No additional adverse reactions have been identified for the combination of alendronate and colecalciferol.
Eintrag öffnenFycompa · 4.8 · In the table below, adverse reactions, which were identified based on review of the full Fycompa clinical stud
Eintrag öffnen